Related references
Note: Only part of the references are listed.Additional Treatments to the Local tumour for metastatic prostate cancer-Assessment of Novel Treatment Algorithms (IP2-ATLANTA): protocol for a multicentre, phase II randomised controlled trial
Martin John Connor et al.
BMJ OPEN (2021)
Identification of novel biomarkers and candidate small-molecule drugs in cutaneous melanoma by comprehensive gene microarrays analysis
Jilei Ma et al.
JOURNAL OF CANCER (2021)
Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer
Ai-Min Jiang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2021)
Re: Radical Prostatectomy or Watchful Waiting in Prostate Cancer—29-Year Follow-up
Peter C. Albertsen
EUROPEAN UROLOGY (2020)
Relationship between MLH1, PMS2, MSH2 and MSH6 gene-specific alterations and tumor mutational burden in 1057 microsatellite instability-high solid tumors
Mohamed E. Salem et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Emerging Roles of Estrogen-Regulated Enhancer and Long Non-Coding RNAs
Melina J. Sedano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Long non-coding RNAs and TGF-β signaling in cancer
Panagiotis Papoutsoglou et al.
CANCER SCIENCE (2020)
MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma
M. J. M. van Velzen et al.
CANCER TREATMENT REVIEWS (2020)
Hepatic Stellate Cells and Hepatocarcinogenesis
Anna E. Barry et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
The proapoptotic gene interferon regulatory factor-1 mediates the antiproliferative outcome of paired box 2 gene and tamoxifen
Shixiong Wang et al.
ONCOGENE (2020)
Identification of Metabolism-Associated Prostate Cancer Subtypes and Construction of a Prognostic Risk Model
Yanlong Zhang et al.
FRONTIERS IN ONCOLOGY (2020)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries (vol 68, pg 394, 2018)
F. Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer
Harsimar B. Kaur et al.
HUMAN PATHOLOGY (2019)
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy
Yosuke Togashi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
A robust panel based on tumour microenvironment genes for prognostic prediction and tailoring therapies in stage I-III colon cancer
Rui Zhou et al.
EBIOMEDICINE (2019)
Switch-like enhancement of epithelial-mesenchymal transition by YAP through feedback regulation of WT1 and Rho-family GTPases
JinSeok Park et al.
NATURE COMMUNICATIONS (2019)
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
Zhao Zhang et al.
NATURE COMMUNICATIONS (2019)
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review
Thomas Van den Broeck et al.
EUROPEAN UROLOGY (2019)
Enhancer RNAs (eRNAs): New Insights into Gene Transcription and Disease Treatment
Mengting Ding et al.
JOURNAL OF CANCER (2018)
SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein
C. Geng et al.
ONCOGENE (2017)
Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer (vol 5, 39, 2017)
Sotirios P. Fortis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Time-dependent ROC curve analysis in medical research: current methods and applications
Adina Najwa Kamarudin et al.
BMC MEDICAL RESEARCH METHODOLOGY (2017)
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Jesse M. Engreitz et al.
NATURE (2016)
Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation
Jun Liang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Identification of activated enhancers and linked transcription factors in breast, prostate, and kidney tumors by tracing enhancer networks using epigenetic traits
Suhn Kyong Rhie et al.
EPIGENETICS & CHROMATIN (2016)
Long ncRNA expression associates with tissue-specific enhancers
Dubravka Vucicevic et al.
CELL CYCLE (2015)
Estrogen upregulates MICA/B expression in human non-small cell lung cancer through the regulation of ADAM17
Jing Ren et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Regularization Paths for Cox's Proportional Hazards Model via Coordinate Descent
Noah Simon et al.
Journal of Statistical Software (2015)
Evaluating Random Forests for Survival Analysis Using Prediction Error Curves
Ulla B. Mogensen et al.
Journal of Statistical Software (2015)
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
Beifang Niu et al.
BIOINFORMATICS (2014)
NRAV, a Long Noncoding RNA, Modulates Antiviral Responses through Suppression of Interferon-Stimulated Gene Transcription
Jing Ouyang et al.
CELL HOST & MICROBE (2014)
Regularization Paths for Generalized Linear Models via Coordinate Descent
Jerome Friedman et al.
JOURNAL OF STATISTICAL SOFTWARE (2010)
Share Paper
